Clinical Trial Update: Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports safety and efficacy results from Phase 2 and Phase 3 studies of ZP-Zolmitriptan intracutaneous microneedle systems for acute …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• ZP-Zolmitriptan (zolmitriptan)

Snippet

Sponsor: Zosano Pharma Corporation | Conditions: Acute Migraine | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2018-02-14